Ignite Creation Date:
2024-05-06 @ 2:15 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT02000596
Status:
TERMINATED
Last Update Posted:
2022-05-27
First Post:
2013-11-21
Brief Title:
1303GCC Trastuzmab Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Organization Data
Organization:
University of Maryland Baltimore
Class:
OTHER
Study ID:
HP-00054959 1303GCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Maryland Baltimore
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |